South African regulator approves Pfizer/BioNTech vaccine for emergency use

PUBLISHED: Tue, 16 Mar 2021 13:56:09 GMT

JOHANNESBURG, March 16 (Reuters) – South Africa’s drugs regulator SAHPRA said on Tuesday that it had approved a “section 21” emergency use application for the COVID-19 vaccine developed by Pfizer and BioNTech.

SAHPRA added in a statement that the approval was subject to further efficacy and safety surveillance of the vaccine in the country, including against the dominant local coronavirus variant.

(Reporting by Alexander Winning and Wendell Roelf)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.